SP-MHCI-0759-3

Human Histone H4.1 90-103, ALKRQGRTLYGFGG

US$507.00

In stock

Description

About Human Histone H4.1 90-103, ALKRQGRTLYGFGG

The Human Histones H4.1 Peptide (IEDB: 419495) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Histones Peptide, H-ALKRQGRTLYGFGG-OH (Uniprot: P62805 aa: 90-103) from JPT is produced under strict quality control and quality management.

Human Histone H4.1 90-103, ALKRQGRTLYGFGG - Specifications

  • Peptide sequence: H-ALKRQGRTLYGFGG-OH
  • Amount: 10 mg (10 x 1 mg)
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Breast cancer
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Peptide Synthesis Services!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for Human Histone H4.1 90-103, ALKRQGRTLYGFGG

References:
Read References with JPT’s Antigen Peptides
Human Histone H4.1 90-103, ALKRQGRTLYGFGG has been described in:
Early Kinetics of the HLA Class I-Associated Peptidome of MVA.HIVconsv-Infected Cells., J Virol, 2015 (PMID: 25810538)
Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires., Immunogenetics, 2015 (PMID: 25502872)
Immunological evaluation of individualized peptide vaccination with a low dose of estramustine for HLA-A24+ HRPC patients., Prostate, 2005 (PMID: 15378520)

Documentation

Documentation for Human Histone H4.1 90-103, ALKRQGRTLYGFGG

Properties

Properties of Human Histone H4.1 90-103, ALKRQGRTLYGFGG

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Breast cancer
Layout: Freeze-dried in glass vial
Organism: Human
Protein Name: Histones
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to Human Histone H4.1 90-103, ALKRQGRTLYGFGG

Information Values
Sequence: H-ALKRQGRTLYGFGG-OH
Specifications: 14mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote